Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-65
SponsorVanda Pharmaceuticals
About this trial
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Parent or legal guardian of individual with Smith-Magenis Syndrome
Disqualifiers
Not legal guardian of individual with SMS
Trial population
Individuals with SMS
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Data collection of sleep disturbances in individuals with SMS
Other interventionData related to Smith-Magenis syndrome and sleep disturbances are collected through a web or phone survey
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Number of individuals with Smith- Magenis syndrome
Time frame
5 yearsSecondary outcomes
1
Sleep Disturbances
Time frame
Up to 100 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov